El-Sappagh Shaker, Kwak Daehan, Ali Farman, Kwak Kyung-Sup
Information Systems Department, Faculty of Computers and Informatics, Benha University, Banha Mansura Road, Meit Ghamr - Benha, Banha, Al Qalyubia Governorate, 3000-104, Egypt.
Department of Computer Science, Kean University, Union, NJ, 07083, USA.
J Biomed Semantics. 2018 Feb 6;9(1):8. doi: 10.1186/s13326-018-0176-y.
Treatment of type 2 diabetes mellitus (T2DM) is a complex problem. A clinical decision support system (CDSS) based on massive and distributed electronic health record data can facilitate the automation of this process and enhance its accuracy. The most important component of any CDSS is its knowledge base. This knowledge base can be formulated using ontologies. The formal description logic of ontology supports the inference of hidden knowledge. Building a complete, coherent, consistent, interoperable, and sharable ontology is a challenge.
This paper introduces the first version of the newly constructed Diabetes Mellitus Treatment Ontology (DMTO) as a basis for shared-semantics, domain-specific, standard, machine-readable, and interoperable knowledge relevant to T2DM treatment. It is a comprehensive ontology and provides the highest coverage and the most complete picture of coded knowledge about T2DM patients' current conditions, previous profiles, and T2DM-related aspects, including complications, symptoms, lab tests, interactions, treatment plan (TP) frameworks, and glucose-related diseases and medications. It adheres to the design principles recommended by the Open Biomedical Ontologies Foundry and is based on ontological realism that follows the principles of the Basic Formal Ontology and the Ontology for General Medical Science. DMTO is implemented under Protégé 5.0 in Web Ontology Language (OWL) 2 format and is publicly available through the National Center for Biomedical Ontology's BioPortal at http://bioportal.bioontology.org/ontologies/DMTO . The current version of DMTO includes more than 10,700 classes, 277 relations, 39,425 annotations, 214 semantic rules, and 62,974 axioms. We provide proof of concept for this approach to modeling TPs.
The ontology is able to collect and analyze most features of T2DM as well as customize chronic TPs with the most appropriate drugs, foods, and physical exercises. DMTO is ready to be used as a knowledge base for semantically intelligent and distributed CDSS systems.
2型糖尿病(T2DM)的治疗是一个复杂的问题。基于海量分布式电子健康记录数据的临床决策支持系统(CDSS)可以促进这一过程的自动化并提高其准确性。任何CDSS最重要的组成部分是其知识库。该知识库可以使用本体来构建。本体的形式描述逻辑支持隐藏知识的推理。构建一个完整、连贯、一致、可互操作且可共享的本体是一项挑战。
本文介绍了新构建的糖尿病治疗本体(DMTO)的第一个版本,作为与T2DM治疗相关的共享语义、特定领域、标准、机器可读且可互操作知识的基础。它是一个全面的本体,提供了关于T2DM患者当前状况、既往病历以及与T2DM相关方面(包括并发症、症状、实验室检查、相互作用、治疗计划(TP)框架以及与葡萄糖相关的疾病和药物)的编码知识的最高覆盖率和最完整图景。它遵循开放生物医学本体铸造厂推荐的设计原则,并基于遵循基础形式本体和通用医学科学本体原则的本体实在论。DMTO以Web本体语言(OWL)2格式在Protégé 5.0下实现,并可通过国家生物医学本体中心的BioPortal在http://bioportal.bioontology.org/ontologies/DMTO上公开获取。DMTO的当前版本包括超过10700个类、277个关系、39425个注释、214个语义规则和62974个公理。我们为这种TP建模方法提供了概念验证。
该本体能够收集和分析T2DM的大多数特征,并使用最合适的药物、食物和体育锻炼来定制慢性TP。DMTO已准备好用作语义智能和分布式CDSS系统的知识库。